Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Clinical expression of LRRK2 G2019S mutations in the elderlyMarta San Luciano, Richard B Lipton, Cuiling Wang, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2007
Validity of spiral analysis in early Parkinson's diseaseRachel Saunders-Pullman, Carol Derby, Kaili Stanley, et al.Neurobiology of Aging|July 22, 2017
Cognitive and motor functioning in elderly glucocerebrosidase mutation carriersEileen E Moran, Cuiling Wang, Mindy Katz, et al.Frontiers in Neurology|August 23, 2024
Multiple sclerosis in LRRK2 G2019S Parkinson's disease and isolated nigral degeneration in a homozygous variant carrierAdina Wise, Roberto A Ortega, Deborah Raymond, et al.Neurology. Clinical Practice|May 10, 2021
Genetic Testing for Parkinson Disease: Are We Ready?Lola Cook, Jeanine Schulze, Catherine Kopil, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2011
Pallidal deep brain stimulation for DYT6 dystoniaFedor Panov, Michele Tagliati, Laurie J Ozelius, et al.Ebiomedicine|February 4, 2018
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher DiseaseJinlong Jian, Yuehong Chen, Rossella Liberti, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 7, 2010
LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseRachel Saunders-Pullman, Matthew J Barrett, Kaili M Stanley, et al.Plos One|October 13, 2016
Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's DiseaseMarta San Luciano, Cuiling Wang, Roberto A Ortega, et al.Clinical Neurology and Neurosurgery|August 21, 2021
Using computerized spiral analysis to evaluate deep brain stimulation outcomes in Parkinson diseaseSara Radmard, Roberto A Ortega, Blair Ford, et al.Pageof 13